MALARIA PARASITAEMIA AMONG FEBRILE CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS IN THE CONTEXT OF PROPHYLACTIC

Insights

Malaria parasitaemia remains high in febrile HIV-infected children in Kenya, despite cotrimoxazole prophylaxis. Findings suggest a need to expand malaria prevention to older children.

Area of Science:

  • Pediatric Infectious Diseases
  • Global Health
  • HIV/AIDS Research

Background:

  • Malaria and HIV co-infection pose significant challenges in endemic regions.
  • Cotrimoxazole prophylaxis is a standard intervention for febrile illnesses in HIV-infected children.

Purpose of the Study:

  • To determine the prevalence of malaria parasitaemia in febrile, HIV-infected children in Western Kenya.
  • To identify factors associated with malaria parasitaemia in this population.

Main Methods:

  • A cross-sectional study was conducted with 245 febrile HIV-infected children (<14 years) at a pediatric HIV clinic in Western Kenya.
  • Systematic sampling was used, and blood samples were analyzed for malaria parasites. Clinical and demographic data were collected.

Main Results:

  • Malaria prevalence was high at 81.9% among the participants.
  • Factors associated with malaria included male sex, parental caretaking, advanced HIV disease (WHO stages 3 & 4), and high CD4 counts, though only caretaking was statistically significant.
  • Despite 97% receiving cotrimoxazole prophylaxis, malaria rates were high.

Conclusions:

  • High malaria parasitaemia persists in febrile HIV-infected children, even with widespread cotrimoxazole use.
  • A shift towards older children experiencing fever suggests a need to reassess and expand malaria prevention strategies to include this age group.
Abstract